|
Mammary Neoplasms
|
0.700 |
GeneticVariation
|
group |
LHGDN |
TP53 mutations in breast cancer: association with ductal histology and early relapse of disease.
|
18949740 |
2009 |
|
Mammary Neoplasms
|
0.700 |
GeneticVariation
|
group |
LHGDN |
Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer.
|
18230179 |
2008 |
|
Mammary Neoplasms
|
0.700 |
GeneticVariation
|
group |
LHGDN |
Effect of p53 codon 72 genotype on breast cancer survival depends on p53 gene status.
|
18348141 |
2008 |
|
Mammary Neoplasms
|
0.700 |
GeneticVariation
|
group |
LHGDN |
TP53 mutations in synchronous and metachronous bilateral breast carcinomas.
|
18617062 |
2008 |
|
Mammary Neoplasms
|
0.700 |
Biomarker
|
group |
LHGDN |
Role of GSTM1 (Null/Present), GSTP1 (Ile105Val) and P53 (Arg72Pro) genetic polymorphisms and the risk of breast cancer: a case control study from South India.
|
17696741 |
2008 |
|
Mammary Neoplasms
|
0.700 |
Biomarker
|
group |
LHGDN |
p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes.
|
18325917 |
2008 |
|
Mammary Neoplasms
|
0.700 |
GeneticVariation
|
group |
LHGDN |
Breast-cancer stromal cells with TP53 mutations and nodal metastases.
|
18094375 |
2007 |
|
Mammary Neoplasms
|
0.700 |
Biomarker
|
group |
LHGDN |
Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium.
|
17909070 |
2007 |
|
Mammary Neoplasms
|
0.700 |
PosttranslationalModification
|
group |
LHGDN |
The screening of the second-site suppressor mutations of the common p53 mutants.
|
17417775 |
2007 |
|
Mammary Neoplasms
|
0.700 |
GeneticVariation
|
group |
LHGDN |
A comparison among HER2, TP53, PAI-1, angiogenesis, and proliferation activity as prognostic variables in tumours from 408 patients diagnosed with early breast cancer.
|
18465330 |
2008 |
|
Mammary Neoplasms
|
0.700 |
AlteredExpression
|
group |
LHGDN |
Our data clearly show neither association between SNP309 and cancer risk, nor the responsibility of G allele for increased MDM2 or decreased of p53 protein levels in human primary breast tumors.
|
18547962 |
2008 |
|
Mammary Neoplasms
|
0.700 |
GeneticVariation
|
group |
LHGDN |
The p53 Arg72Pro and MDM2 -309 polymorphisms and risk of breast cancer in the nurses' health studies.
|
17387621 |
2007 |
|
Mammary Neoplasms
|
0.700 |
GeneticVariation
|
group |
LHGDN |
Impaired p53 function leads to centrosome amplification, acquired ERalpha phenotypic heterogeneity and distant metastases in breast cancer MCF-7 xenografts.
|
18264135 |
2008 |
|
Mammary Neoplasms
|
0.700 |
AlteredExpression
|
group |
LHGDN |
Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells.
|
18158619 |
2008 |
|
Mammary Neoplasms
|
0.700 |
GeneticVariation
|
group |
LHGDN |
Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients.
|
17537232 |
2007 |
|
Mammary Neoplasms
|
0.700 |
AlteredExpression
|
group |
LHGDN |
Targeted repression of bone morphogenetic protein 7, a novel target of the p53 family, triggers proliferative defect in p53-deficient breast cancer cells.
|
17909016 |
2007 |
|
Mammary Neoplasms
|
0.700 |
AlteredExpression
|
group |
LHGDN |
Protein kinase C epsilon confers resistance of MCF-7 cells to TRAIL by Akt-dependent activation of Hdm2 and downregulation of p53.
|
18317451 |
2008 |
|
Mammary Neoplasms
|
0.700 |
GeneticVariation
|
group |
LHGDN |
Association of polymorphism in MDM-2 and p53 genes with breast cancer risk in Indian women.
|
17719241 |
2008 |
|
Mammary Neoplasms
|
0.700 |
Biomarker
|
group |
LHGDN |
Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
|
17699779 |
2007 |
|
Mammary Neoplasms
|
0.700 |
GeneticVariation
|
group |
LHGDN |
Role of p53 codon 72 arginine allele in cell survival in vitro and in the clinical outcome of patients with advanced breast cancer.
|
18612219 |
2008 |
|
Mammary Neoplasms
|
0.700 |
Biomarker
|
group |
LHGDN |
Sodium butyrate induces P53-independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells.
|
11786482 |
2002 |
|
Mammary Neoplasms
|
0.700 |
GeneticVariation
|
group |
LHGDN |
CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer.
|
18725978 |
2008 |
|
Mammary Neoplasms
|
0.700 |
GeneticVariation
|
group |
LHGDN |
Associations between common polymorphisms in TP53 and p21WAF1/Cip1 and phenotypic features of breast cancer.
|
11872638 |
2002 |
|
Mammary Neoplasms
|
0.700 |
AlteredExpression
|
group |
LHGDN |
Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion.
|
19141643 |
2009 |
|
Mammary Neoplasms
|
0.700 |
AlteredExpression
|
group |
LHGDN |
Apoptosis induced by baicalin involving up-regulation of P53 and bax in MCF-7 cells.
|
19031258 |
2009 |